2026³â 04¿ù 30ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Business

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

René Lammers Appointed Chief Research & Innovation Officer of The Estée Lauder Companies

´º½ºÀÏÀÚ: 2025-10-02

NEW YORK -- The Estée Lauder Companies Inc. (NYSE: EL) announced the appointment of René Lammers, Ph.D. as Executive Vice President, Chief Research & Innovation Officer, effective October 1, 2025. Mr. Lammers will report directly to Stéphane de La Faverie, President and Chief Executive Officer, and will join the company’s Executive Team.

“René is an exceptional and innovative leader whose deep scientific expertise, global perspective, and passion for cutting-edge product development will be instrumental as we transform our approach to research and innovation to more fully align with our focus on consumer centricity,” said Mr. de La Faverie. “Creating transformative innovation is integral to our strategic vision of Beauty Reimagined, and with René’s leadership, we are elevating our capabilities to deliver even more breakthrough new products as well as on-trend innovation more quickly across prestige price tiers. With this appointment, I am excited that my Executive Team is now complete and positioned to lead the company into its next chapter of growth and transformation.”

As Chief Research & Innovation Officer, Mr. Lammers will lead the evolution of The Estée Lauder Companies’ global Research & Innovation capabilities, including product and clinical innovation, scientific affairs, regulatory strategy, and upstream technologies across the company’s brand portfolio. He will help advance the company’s high-touch innovation model, bringing forward disruptive technologies and new science-based platforms that elevate performance, quality, safety, and sustainability. He will oversee the company’s Research and Innovation Centers worldwide and place a focus on delivering fast-to-market, on-trend innovation across in-demand subcategories, benefits and occasions. He will also advance collaborations with leading global scientific and academic institutions, and drive further external innovation with strategic partners, particularly in critical areas like biotechnology and longevity science.

Drawing on nearly 30 years of experience, Mr. Lammers brings a rare blend of deep scientific expertise with a passion for serving consumers, making him an ideal leader to Create Transformative Innovation, which is one of the action plan priorities of Beauty Reimagined. His consumer-first mindset and proven ability to develop and scale global innovations will help unlock new growth across categories and channels while reinforcing its legacy of scientific excellence and consumer trust.

Mr. Lammers joins The Estée Lauder Companies from PepsiCo, where he most recently served as Executive Vice President and Chief Science Officer, overseeing a 3,000-person global Research & Development organization. There, he created and scaled some of the world’s most beloved food and beverage products, shaping innovations that reached and delighted diverse consumers across the globe. He spearheaded PepsiCo’s science and technology agenda, scaling billion-dollar platforms, and driving breakthrough innovation and sustainability advances that blended scientific rigor with consumer insights. Prior to PepsiCo, René held senior leadership positions at Unilever, where he developed pioneering technologies across personal care, home care, and laundry, and established innovation hubs across Europe and Asia.

Mr. Lammers holds a Ph.D. in organic chemistry from Delft University of Technology and a master’s degree from Leiden University. He currently serves on the Board of the New York Hall of Science and is a Commissioner for the National Commission on Innovation and Competitiveness Frontiers, an initiative of the U.S. Council on Competitiveness.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth
Biocytogen Grants Taisho Pharma License for RenNano Human Heavy Chain-Only Antibody Platform
Company Expands Presence in European Built-in Market With Tailored Innovations Reflecting Latest Design and Lifestyle Trends
APAC Insurers Are Racing into Private Markets. Their Infrastructure Is Not Keeping Up
NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility
M1X Global Announces Public Launch and Oversubscribed $3 Million Angel Round to Scale On-Chain Sovereign Finance
Nearly Half of Global C-Suites Plan U.S. Expansion Within 12 Months, as Supply Chain and Capital Access Drive Growth

 

VIDAA Set to Overtake LG¡¯s webOS in Europe as Chinese TV Brands Gain ...
Porsche Sells Bugatti Stake to BlueFive Capital
LG Electronics Reinforces Presence in Premium Built-in Market at Milan...
Andersen Consulting Enters Collaboration Agreement with SolutiaSAN FRA...
Visa Launches Enhanced Subscription Manager, Giving Consumers Greater ...
AI Is Now Foundational to Modern Marketing
Amazfit Unveils the Cheetah 2 Pro, a Performance Running Watch Built f...

 


°øÁö»çÇ×
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ÃÁö'
'º£³×ÀÍ' Áß¹® Ç¥±â 宝Ò¬ìÌ, 'À̺ñÁî: ÀÌÁö' Áß¹® Ç¥±â æ¶币òª...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®À¯ºñ Alliuv ä¹备: ä¹êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØ, À£ÇÁ·Ò Welfrom 卫ÜØ
¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备 äþÒöêóÝá
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØ ä¹ì³ÜØ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..